Alvimopan
What is Alvimopan?[edit | edit source]
- Alvimopan (Entereg) is an opioid antagonist used for the treatment of postoperative ileus.
What are the uses of this medicine?[edit | edit source]
- Alvimopan (Entereg) is used in people to avoid postoperative ileus following partial large or small bowel resection with primary anastomosis.
- Alvimopan accelerates the gastrointestinal recovery period as defined by time to first bowel movement or flatus.
How does this medicine work?[edit | edit source]
- Alvimopan is a selective antagonist of the cloned human μ-opioid receptor.
- Postoperative ileus is the impairment of gastrointestinal motility after intra-abdominal surgery or other, non-abdominal surgeries. Postoperative ileus affects all segments of the gastrointestinal tract and may last from 5 to 6 days, or even longer.
- This may potentially delay gastrointestinal recovery and hospital discharge until its resolution.
- It is characterized by abdominal distention and bloating, nausea, vomiting, pain, accumulation of gas and fluids in the bowel, and delayed passage of flatus and defecation.
- Morphine and other μ-opioid receptor agonists are universally used for the treatment of acute postsurgical pain; however, they are known to have an inhibitory effect on gastrointestinal motility and may prolong the duration of postoperative ileus.
- Following oral administration, alvimopan antagonizes the peripheral effects of opioids on gastrointestinal motility and secretion by competitively binding to gastrointestinal tract μ-opioid receptors.
- Alvimopan achieves this selective gastrointestinal opioid antagonism without reversing the central analgesic effects of μ-opioid agonists.
Who Should Not Use this medicine ?[edit | edit source]
This medicine cannot be used in patients who:
- have taken therapeutic doses of opioids for more than 7 consecutive days immediately prior to taking Entereg.
What drug interactions can this medicine cause?[edit | edit source]
- Dosage adjustment for intravenously administered morphine is not necessary when it is coadministered with Entereg.
- No dosage adjustments are necessary in patients taking acid blockers or antibiotics with Entereg.
Is this medicine FDA approved?[edit | edit source]
- It was approved for the treatment of postoperative ileus which it received in May 2008.
How should this medicine be used?[edit | edit source]
Recommended dosage:
- The recommended adult dosage of Entereg is 12 mg administered 30 minutes to 5 hours prior to surgery followed by 12 mg twice daily beginning the day after surgery until discharge for a maximum of 7 days.
- Patients should not receive more than 15 doses of Entereg.
Administration:
- Entereg can be taken with or without food.
What are the dosage forms and brand names of this medicine?[edit | edit source]
This medicine is available in fallowing doasage form:
- As Capsules: 12 mg
This medicine is available in fallowing brand namesː
- Entereg
What side effects can this medication cause?[edit | edit source]
The most common side effects of this medicine include:
What special precautions should I follow?[edit | edit source]
- A higher number of myocardial infarctions was reported in patients treated with Entereg 0.5 mg twice daily compared with placebo in a 12-month study in patients treated with opioids for chronic non-cancer pain, although a causal relationship with long-term use has not been established.
- Patients recently exposed to opioids may be more sensitive to the effects of Entereg and experience gastrointestinal adverse reactions (e.g., abdominal pain, nausea and vomiting, and diarrhea).
- Patients with severe hepatic impairment may be at higher risk of serious adverse reactions (including dose-related serious adverse reactions). Therefore, the use of Entereg is not recommended in this population.
- No studies have been conducted in patients with end-stage renal disease. Entereg is not recommended for use in these patients.
- No studies have been conducted in patients with complete gastrointestinal obstruction or in patients who have surgery for correction of complete bowel obstruction; use is not recommended.
- Entereg has not been studied in patients having pancreatic or gastric anastomosis. Therefore, Entereg is not recommended for use in these patients.
What to do in case of emergency/overdose?[edit | edit source]
- In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.
- Overdose related information is also available online at poisonhelp.org/help.
- In the event that the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services. In the United States, call 911.
Can this medicine be used in pregnancy?[edit | edit source]
- Available data regarding use of Entereg in pregnant women are limited, and are insufficient to inform a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.
Can this medicine be used in children?[edit | edit source]
- Safety and effectiveness in pediatric patients have not been established.
What are the active and inactive ingredients in this medicine?[edit | edit source]
Active ingredient:
- alvimopan
Inactive ingredients:
- POLYETHYLENE GLYCOL, UNSPECIFIED
- GELATIN, UNSPECIFIED
Who manufactures and distributes this medicine?[edit | edit source]
Manufactured for:
- Merck Sharp & Dohme Corp., a subsidiary of
- MERCK & CO., INC., Whitehouse Station, NJ, USA
Manufactured by:
- Pharmaceutical Manufacturing Research Services, Inc., Horsham, PA, USA
What should I know about storage and disposal of this medication?[edit | edit source]
- Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F).
Alvimopan Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju